These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11985373)

  • 21. [Joint program of pharmacovigilance in Quebec: comparison with France, Aquitaine and the Basque region].
    Biron P; Balency D
    Therapie; 1996; 51(5):578-81. PubMed ID: 9138400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retrospective study of adverse drug reactions in the elderly: experience of regional center for pharmacovigilance].
    Bruneau S; Bruhat C; Lagarce L; Lainé-Cessac P
    Therapie; 2001; 56(6):785-91. PubMed ID: 11878111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Features of the French postmarketing drug surveillance system. Application to cutaneous effects of nonsteroidal antiinflammatory drugs.
    Albengres E
    J Rheumatol Suppl; 1988 Oct; 17():20-3. PubMed ID: 3204616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updating the French method for the causality assessment of adverse drug reactions.
    Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
    Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug related falls: a study in the French Pharmacovigilance database.
    Souchet E; Lapeyre-Mestre M; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):11-6. PubMed ID: 15508129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Veterinary pharmacovigilance in the European context.
    Keck G
    Ann Ist Super Sanita; 1992; 28(4):425-8. PubMed ID: 1303032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of tolerance to endovesical BCG treatment in France: analysis of severe adverse effects notified in 3 years].
    Debois H; Loupi E; Saliou P; Blangy H; Loeuille D; Gillet P
    Prog Urol; 2001 Jun; 11(3):458-65. PubMed ID: 11512458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [French system of drug surveillance].
    Imbs JL; Castot A; Begaud B; Larousse C; Blayac JP; Alexandre JM
    Bull Acad Natl Med; 1998; 182(7):1383-91; discussion 1392-3. PubMed ID: 9916332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption.
    Gaubert S; Vié M; Damase-Michel C; Pathak A; Montastruc JL
    Fundam Clin Pharmacol; 2009 Apr; 23(2):247-52. PubMed ID: 19298233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A 30-month study of the calls to the Regional Drug Monitoring Center in Lorraine (Nancy)].
    Trechot PF; Royer RJ; Gaire M; Gaspard MC; Netter P
    Therapie; 1990; 45(1):43-6. PubMed ID: 2343435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reaction monitoring and the Internet: evaluation of the use of the Internet by French Pharmacovigilance Centres and a non-exhaustive survey of websites of interest for collecting information about adverse drug reaction.
    Morel P; Vandel B
    Therapie; 1999; 54(5):525-32. PubMed ID: 10667084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system.
    Tiaden JD; Wenzel E; Berthold HK; Müller-Oerlinghausen B
    Semin Thromb Hemost; 2005; 31(4):371-80. PubMed ID: 16149013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Good practices in pharmacovigilance. Drugs for human use].
    Therapie; 1995; 50(6):547-55. PubMed ID: 8745955
    [No Abstract]   [Full Text] [Related]  

  • 39. [Events and adverse reactions in biovigilance: Descriptive analysis of French national data following a four-year practical experience].
    Martinière K; Lucas S; Zorzi P
    Transfus Clin Biol; 2008 Sep; 15(4):179-89. PubMed ID: 18538607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacovigilance as new direction of research].
    Gaszner G; Makkos Z; Gaszner P
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.